Hudson Bay Capital Management LP Genprex, Inc. Transaction History

Hudson Bay Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.9 - $4.29 $126,329 - $186,880	-43,562 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.99 - $3.64 $86,688 - $158,565	43,562 New	43,562 $136,000
Q4 2018 Feb 13, 2019	SELL	$1.0 - $2.15 $379,064 - $814,987	-379,064 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.2 - $8.08 $77,409 - $284,302	-35,186 Reduced 8.49%	379,064 $860,000
Q2 2018 Aug 13, 2018	BUY	$3.84 - $15.9 $1.59 Million - $6.59 Million	414,250 New	414,250 $2.94 Million

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $37M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.